共 50 条
- [31] A randomized double-blind phase III study of niraparib versus placebo as maintenance therapy in extensive-stage small cell lung cancerANNALS OF ONCOLOGY, 2020, 31 : S1387 - S1387Ai, X.Pan, Y.Shi, J.Yang, N.Liu, C.Zhou, J.Zhang, X.Dong, X.He, J.Li, X.Chen, G.Li, X.Zhang, H.Liao, W.Zhang, Y.Ma, Z.Zhang, B.Zhang, D.Lu, S.
- [32] A phase II study of toripalimab plus anlotinib as maintenance therapy in extensive-stage small cell lung cancer.CANCER RESEARCH, 2021, 81 (13)Lv, DongqingWu, GuixianLin, XiaomaiLin, LingPan, Weijia
- [33] Phase Ib expansion study of adavosertib plus olaparib in patients with extensive-stage or relapsed small cell lung cancerANNALS OF ONCOLOGY, 2020, 31 : S1035 - S1035Li, B. T.Hamilton, E. P.Wang, J. S.Falchook, G. S.Oza, A. M.Imedio, E. RodrigoKumar, S.Mugundu, G. M.De Bruin, E.Spigel, D. R.Fu, S.
- [34] Prognostic Laboratory Parameters in Imfirst: Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung CancerJOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S662 - S663de Castro, J.Cobo Dols, M.Domine Gomez, M.Moreno Vega, A.Ponce Aix, S.Arriola, E.Carcereny, E.Majem, M.Huidobro Vence, G.Esteban Gonzalez, E.Fuentes Pradera, J.Ortega Granados, A. L.Guillot Morales, M.Massuti Sureda, B.Fernandez Nunez, N.Provencio, M.Gonzalez-Mancha, N.Fajardo, C. A.Lerones, N.Garcia Campelo, R.
- [35] First-line apatinib plus chemotherapy in extensive-stage small-cell lung cancer.JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)Shi, JianLiu, JiayinDuan, XiaoyangHuang, GuangleiWang, LixingZhao, Yan
- [36] Cost-effectiveness analysis of serplulimab combined with chemotherapy in the treatment of extensive-stage small-cell lung cancer from the perspective of the healthcare system in ChinaBMJ OPEN, 2023, 13 (08):Long, YunchunXu, YuanLiao, LiZhou, YujieWang, Hao
- [37] Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancerJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)Zhou, FeiZhao, WenchengGong, XiaomeiRen, ShengxiangSu, ChunxiaJiang, TaoZhou, Caicun
- [38] Alternating Chemotherapy with Amrubicin Plus Cisplatin and Weekly Administration of Irinotecan Plus Cisplatin for Extensive-stage Small Cell Lung CancerANTICANCER RESEARCH, 2013, 33 (03) : 1117 - 1123Noro, RintaroYoshimura, AkinobuYamamoto, KazuoMiyanaga, AkihikoMizutani, HideakiMinegishi, YujiSeike, MasahiroKubota, KaoruKosaihira, SeijiHino, MitsunoriAndo, MasahiroNomura, KoichiroOkano, TetsuyaKobayashi, KunihikoUematsu, KazutsuguGemma, Akihiko
- [39] Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer The Phase 3 EXTENTORCH Randomized Clinical TrialJAMA ONCOLOGY, 2025, 11 (01) : 16 - 25Cheng, YingZhang, WeiWu, LinZhou, CaicunWang, DonglinXia, BingBi, MinghongFu, XiuhuaLi, ChongLv, DongqingZhao, YanqiuChen, GongyanYi, TienanHuang, JiananLi, MinYang, RunxiangHuang, XiaopingWang, YeZhang, MingjunPan, YueyinSun, YilanHu, ShengZhang, XiqinZhou, MinFang, JianJin, FaguangLiu, YunpengLi, YinyinZhang, ZhihongHu, JieLiu, LaiyuWang, RuiLi, YanGu, KangshengDing, CuiminFan, QingxiaZhang, GuojunChen, YongxingJiang, LiyanZheng, Wei-E.Chen, ShaoshuiHuang, ChengHan, ZhigangYang, HongWang, JianfangWang, BaochengWu, HuitaBao, YongxingLi, ManxiangLuo, Xianming
- [40] RANDOMIZED COMPARISON OF LOBAPLATIN PLUS ETOPOSIDE AND CISPLATIN PLUS ETOPOSIDE CHEMOTHERAPY IN PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCERJOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S493 - S493Guo, Feng W.Liao, Qing G.Gao, Jun H.Wang, Mei H.Tang, Hao C.Qing, Peng H.Li, Jie J.